|
US4105602A
(en)
*
|
1975-02-10 |
1978-08-08 |
Armour Pharmaceutical Company |
Synthesis of peptides with parathyroid hormone activity
|
|
US4086196A
(en)
*
|
1975-03-28 |
1978-04-25 |
Armour Pharmaceutical Company |
Parathyroid hormone
|
|
US4301045A
(en)
*
|
1977-05-02 |
1981-11-17 |
Armour Pharmaceutical Company |
Synthesis of peptides
|
|
IL59690A
(en)
|
1980-03-24 |
1983-11-30 |
Yeda Res & Dev |
Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
|
|
US4621053A
(en)
*
|
1980-07-30 |
1986-11-04 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Process for the production of human peptide hormones
|
|
SE453510B
(sv)
*
|
1980-12-29 |
1988-02-08 |
Toyo Jozo Kk |
Peptid for analys av humant paratyroidhormon
|
|
US4423037A
(en)
*
|
1982-05-13 |
1983-12-27 |
The General Hospital Corporation |
Inhibitors of peptide hormone action
|
|
FR2550204B1
(fr)
*
|
1983-08-05 |
1987-11-13 |
Toyo Jozo Kk |
Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
|
|
US5116952A
(en)
*
|
1986-07-18 |
1992-05-26 |
The University Of Melbourne |
Protein active in humoral hypercalcemia of malignancy-pthrp
|
|
US5420242A
(en)
*
|
1986-10-22 |
1995-05-30 |
Kaare M. Gautvik |
Production of human parathyroid hormone from microorganisms
|
|
WO1988003165A1
(en)
|
1986-10-22 |
1988-05-05 |
Selmer Sande A.S. |
Production of human parathyroid hormone from microorganisms
|
|
US4771124A
(en)
*
|
1987-05-26 |
1988-09-13 |
Merck & Co., Inc. |
Parathyroid hormone antagonists with simplified synthetic methodology
|
|
US5639660A
(en)
*
|
1988-02-24 |
1997-06-17 |
Hoffmann-La Roche Inc. |
Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
|
|
US5114843A
(en)
*
|
1988-05-09 |
1992-05-19 |
Merck & Co., Inc. |
Humoral hypercalcemic factor antagonists
|
|
JPH03504201A
(ja)
*
|
1989-02-23 |
1991-09-19 |
ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング （ゲー・ベー・エフ） |
Ｐｔｈ変種をコードするｄｎａ配列、ｐｔｈ変種、発現ベクター、細菌宿主、利用と治療用組成物
|
|
USRE37919E1
(en)
|
1989-05-12 |
2002-12-03 |
The General Hospital Corporation |
Recombinant DNA method for production of parathyroid hormone
|
|
CA2040264A1
(en)
*
|
1990-04-12 |
1991-10-13 |
Tatsuhiko Kanmera |
Parathyroid hormone antagonists
|
|
JP2952951B2
(ja)
*
|
1990-04-12 |
1999-09-27 |
三菱化学株式会社 |
ペプチド誘導体
|
|
AU667662B2
(en)
*
|
1990-07-13 |
1996-04-04 |
Regents Of The University Of California, The |
Parathyroid hormone analogues modified at positions 3, 6 or 9
|
|
US5149779A
(en)
*
|
1990-07-26 |
1992-09-22 |
Merck & Co., Inc. |
Humoral hypercalcemic factor antagonists
|
|
US5208041A
(en)
*
|
1991-05-23 |
1993-05-04 |
Allelix Biopharmaceuticals Inc. |
Essentially pure human parathyroid hormone
|
|
US5814603A
(en)
*
|
1992-06-12 |
1998-09-29 |
Affymax Technologies N.V. |
Compounds with PTH activity
|
|
AU672790B2
(en)
*
|
1992-07-15 |
1996-10-17 |
Novartis Ag |
Variants of parathyroid hormone and its fragments
|
|
US5849695A
(en)
*
|
1993-01-13 |
1998-12-15 |
The Regents Of The University Of California |
Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
|
|
DE69713485T2
(de)
*
|
1996-02-01 |
2003-01-30 |
Chugai Seiyaku K.K., Tokio/Tokyo |
Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
|
|
TW505654B
(en)
|
1996-07-30 |
2002-10-11 |
Hoffmann La Roche |
Synthesis of analogs of PTH and PTHrP
|
|
SE9702401D0
(sv)
*
|
1997-06-19 |
1997-06-19 |
Astra Ab |
Pharmaceutical use
|
|
AU5877300A
(en)
*
|
1999-06-15 |
2001-01-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Pth2 and pth1 receptor ligands
|
|
US6387711B1
(en)
*
|
2000-08-11 |
2002-05-14 |
Quest Diagnostics Investments Incorporated |
Liquid intact parathyroid hormone (PTH) standards
|
|
US6905886B2
(en)
*
|
2000-08-11 |
2005-06-14 |
Quest Diagnostics Investments Incorporated |
Preservative solutions
|
|
AU2002951372A0
(en)
*
|
2002-09-13 |
2002-09-26 |
St Vincent's Institute Of Medical Research |
Parathyroid hormone-like polypeptides
|